International Association for the Study of Lung Cancer Computed Tomography Screening Workshop 2011 Report
International Association for the Study of Lung Cancer Computed Tomography Screening Workshop 2011 Report
复制标题
DOI：
10.1097/jto.0b013e31823c58ab
复制
发表时间：
2012-01-01
影响因子：
20.4
通讯作者：
Mulshine, Jim L.
中科院分区：
文献类型：
--
作者：
Field, John K.;Smith, Robert A.;Mulshine, Jim L.
国际肺癌研究协会（IASLC）董事会召集了一个计算机断层扫描（CT）筛查工作组，以制定IASLC的立场声明。此前，美国国家癌症研究所发表了一份关于全国肺癌筛查试验的新闻声明，显示肺癌死亡率下降了20%。根据从其他器官部位进行癌症筛查的经验，工作组的立场声明概述了进一步改进肺癌CT筛查方法的一些主要机会。2011年IASLC CT筛查研讨会进一步发展了这些讨论，并在本报告中进行了总结。研讨会提出建议，并得到IASLC董事会的支持，成立战略CT筛查咨询委员会（IASLC- ssac）。战略CT筛查咨询委员会目前正在与全球肺癌CT筛查实施的利益相关者专业协会和组织合作，重点在六个特定领域提供指南和建议：(i)确定肺癌CT筛查项目的高危人群；（ii）制定用于制定国家筛查计划的放射学指南；（iii）为CT筛查程序导致的“不确定结节”的临床检查制定指南；（iv）肺癌CT筛查项目中结节病理报告指南；(v)通过肺癌CT筛查项目发现的可疑结节的手术和治疗干预建议；（六）将戒烟实践纳入未来的国家肺癌CT筛查计划。
The International Association for the Study of Lung Cancer (IASLC) Board of Directors convened a computed tomography (CT) Screening Task Force to develop an IASLC position statement, after the National Cancer Institute press statement from the National Lung Screening Trial showed that lung cancer deaths fell by 20%. The Task Force's Position Statement outlined a number of the major opportunities to further improve the CT screening in lung cancer approach, based on experience with cancer screening from other organ sites.The IASLC CT Screening Workshop 2011 further developed these discussions, which are summarized in this report. The recommendation from the workshop, and supported by the IASLC Board of Directors, was to set up the Strategic CT Screening Advisory Committee (IASLC-SSAC). The Strategic CT Screening Advisory Committee is currently engaging professional societies and organizations who are stakeholders in lung cancer CT screening implementation across the globe, to focus on delivering guidelines and recommendations in six specific areas: (i) identification of high-risk individuals for lung cancer CT screening programs; (ii) develop radiological guidelines for use in developing national screening programs; (iii) develop guidelines for the clinical work-up of "in-determinate nodules" resulting from CT screening programmers; (iv) guidelines for pathology reporting of nodules from lung cancer CT screening programs; (v) recommendations for surgical and therapeutic interventions of suspicious nodules identified through lung cancer CT screening programs; and (vi) integration of smoking cessation practices into future national lung cancer CT screening programs.